Clinical Trials Update AHA Congress 2010.

Item

http://www.wikidata.org/entity/Q45867461

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh-hant

name

Clinical Trials Update AHA Congress 2010.

@en

Clinical Trials Update AHA Congress 2010.

@nl

type

Item

label

Clinical Trials Update AHA Congress 2010.

@en

Clinical Trials Update AHA Congress 2010.

@nl

prefLabel

Clinical Trials Update AHA Congress 2010.

@en

Clinical Trials Update AHA Congress 2010.

@nl

P1476

Clinical Trials Update AHA Congress 2010

@en

P2093

Nikolaus Marx

http://www.w3.org/2001/XMLSchema#string

Robert S Rosenson

http://www.w3.org/2001/XMLSchema#string

Willem J Remme

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial

Efficacy and safety of the cholesteryl ester transfer protein inhibitor anacetrapib as monotherapy and coadministered with atorvastatin in dyslipidemic patients

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.

Design and rationale of the Reduction of Infarct Expansion and Ventricular Remodeling with Erythropoietin after Large Myocardial Infarction (REVEAL) trial.

Calcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID Trial), a first-in-human phase 1/2 clinical trial.

Recombinant high-density lipoprotein formulations.

HDL cholesterol and residual risk of first cardiovascular events after treatment with potent statin therapy: an analysis from the JUPITER trial.

Modulating cholesteryl ester transfer protein activity maintains efficient pre-β-HDL formation and increases reverse cholesterol transport.

Cholesterol efflux potential and antiinflammatory properties of high-density lipoprotein after treatment with niacin or anacetrapib.

P304

69-76

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10557-011-6285-9

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

John McMurray

J D Horowitz

P577

2011-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21340529

http://www.w3.org/2001/XMLSchema#string